Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Pharmamar

Clinical trials sponsored by Pharmamar, explained in plain language.

PharmaMar PHM BME

Biopharmaceutical company developing marine-derived anticancer drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1 Completed 4

New hope for leiomyosarcoma: drug combo trial aims to slow tumor growth

Disease control Ongoing

This phase 3 trial tests whether adding lurbinectedin to standard doxorubicin chemotherapy helps people with metastatic leiomyosarcoma live longer without their cancer growing. About 469 adults who have not had prior treatment for advanced disease are being studied. The main goal…

Phase: PHASE3 • Sponsor: PharmaMar • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC